Loading company…
Sera Prognostics develops tests that use biomarkers to assess pregnancy risks, including early preterm birth.
Sera Prognostics develops biomarker tests to assess risks of preterm birth, preeclampsia and other pregnancy complications. Its PreTRM® Test is designed to help pregnant women and doctors understand the risk of early preterm birth. Founded in 2008, the company is based in Salt Lake City, US, and was co-founded by Dennis Farrar, Sean Esplin and Steven Graves.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in